Related references
Note: Only part of the references are listed.Targeting the Hippo pathway: Clinical implications and therapeutics
Shuai Ye et al.
PHARMACOLOGICAL RESEARCH (2016)
Akt and Hippo Pathways in Ewing's Sarcoma Tumors and Their Prognostic Significance
Atif A. Ahmed et al.
JOURNAL OF CANCER (2015)
Safety and Effectiveness of Recombinant Human Bone Morphogenetic Protein-2 for Spinal Fusion A Meta-analysis of Individual-Participant Data
Mark C. Simmonds et al.
ANNALS OF INTERNAL MEDICINE (2013)
Effectiveness and Harms of Recombinant Human Bone Morphogenetic Protein-2 in Spine Fusion A Systematic Review and Meta-analysis
Rongwei Fu et al.
ANNALS OF INTERNAL MEDICINE (2013)
3,3′-Diindolylmethane suppresses the growth of gastric cancer cells via activation of the Hippo signaling pathway
Xiu Juan Li et al.
ONCOLOGY REPORTS (2013)
In Vivo Inhibition of Bone Morphogenetic Protein-2 on Breast Cancer Cell Growth
Shuai Ye et al.
SPINE (2013)
The Hippo pathway and human cancer
Kieran F. Harvey et al.
NATURE REVIEWS CANCER (2013)
Regulators of mammalian Hippo pathway in cancer
Angela M. Liu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2012)
rhBMP-2 has adverse effects on human oral carcinoma cell lines in vivo
Natalia A. Kokorina et al.
LARYNGOSCOPE (2012)
A Breakdown of the Hippo Pathway in Gastric Cancer
Zhi Peng Xu et al.
HEPATO-GASTROENTEROLOGY (2011)
Effects of the Bone Morphogenetic Protein Binding Protein spp24 (Secreted Phosphoprotein 24 kD) on the Growth of Human Lung Cancer Cells
Kwang-Bok Lee et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2011)
Treatment Effects of rhBMP-2 on Invasiveness of Oral Carcinoma Cell Lines
Natalia A. Kokorina et al.
LARYNGOSCOPE (2011)
Recombinant human bone morphogenetic protein-2 and pancreatic cancer: a retrospective cohort study
Daniel Mines et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2011)
A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned
Eugene J. Carragee et al.
SPINE JOURNAL (2011)
Effects of bone morphogenetic protein-2 on proliferation and angiogenesis in oral squamous cell carcinoma
Q. Gao et al.
INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2010)
Expression of Yes-associated protein in common solid tumors
Angela A. Steinhardt et al.
HUMAN PATHOLOGY (2008)
Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control
Bin Zhao et al.
GENES & DEVELOPMENT (2007)
Elucidation of a universal size-control mechanism in Drosophila and mammals
Jixin Dong et al.
CELL (2007)
RASSRA elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the P73 tumor suppressor protein
David Matallanas et al.
MOLECULAR CELL (2007)
RASSF1A is part of a complex similar to the Drosophila Hippo/Salvador/Lats tumor-suppressor network
Cai Guo et al.
CURRENT BIOLOGY (2007)
Bone morphogenetic protein signaling and growth suppression in colon cancer
Stayce E. Beck et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2006)
Role of the tumor suppressor RASSF1A in Mst1-medated apoptosis
HJ Oh et al.
CANCER RESEARCH (2006)
Bone morphogenetic protein 2 stimulation of tumor growth involves the activation of Smad-1/5
EM Langenfeld et al.
ONCOGENE (2006)
Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions
BT Feeley et al.
BONE (2006)
BMP-2 modulates the proliferation and differentiation of normal and cancerous gastric cells
XZ Wen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Regulation of the MST1 kinase by autophosphorylation, by the growth inhibitory proteins, RASSF1 and NORE1, and by Ras
M Praskova et al.
BIOCHEMICAL JOURNAL (2004)
salvador promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines
N Tapon et al.
CELL (2002)
Safety profile for the clinical use of bone morphogenetic proteins in the spine
AR Poynton et al.
SPINE (2002)
Identification of a novel Ras-regulated proapoptotic pathway
A Khokhlatchev et al.
CURRENT BIOLOGY (2002)
RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours
D Astuti et al.
ONCOGENE (2001)
The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis
K Dreijerink et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Epigenetic inactivation of RASSF14 in lung and breast cancers and malignant phenotype suppression
DG Burbee et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3
R Dammann et al.
NATURE GENETICS (2000)
Share Paper
